Michael Lobritz

Michael Lobritz

Michael Lobritz is responsible for the early clinical development of the antibiotics portfolio at Roche, with the objective to bring innovative new antibiotics to patients. Prior to joining Roche in 2017, Michael was a physician-scientist at Massachusetts General Hospital and Harvard Medical School, in Boston, USA, where his academic focus was on the application of systems biology to problems in infectious diseases.